FENC GlobeNewswire 2 days ago Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
FENC MT Newswires 3 days ago B Riley Reaffirms Fennec's Buy Rating, US$16.00 Price Target After Cipla Settlement
FENC MT Newswires 4 days ago Update: Fennec Pharmaceuticals Shares Rise on Settlement of Pedmark Generic Dispute With Cipla
